
The episode discusses the challenges of GLP-1 medication access due to insurance issues and explores potential solutions through direct-to-employer purchasing.
Send us Fan Mail Losing access to a GLP-1 can happen even when treatment is working exactly as intended. A lower BMI, an insurance change, or an employer facing open-ended costs can suddenly turn a prescription into a maze of denials, prior authorizations, and unexpected expenses. In this episode, Ana Reisdorf speaks with Jay Bregman, founder and CEO of Andel, about why traditional insurance struggles to cover high-demand medications and how direct-to-employer purchasing could offer another ...
Explore listener stats, chart rankings, contacts and more on the GLP-1 Hub: Support, Community, and Weight Loss podcast page.